OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
424157

Atect Corp

Medical Equipment, Supplies & DistributionVerified

Atect Corp's capital structure is characterized by a lack of disclosed balance-sheet liquidity metrics, and its liquidity risk remains unassessed due to missing inputs and no going-concern language in source documents. The company has no dilution risk in the near term, as shares outstanding remain unchanged between basic and diluted shares. Profitability metrics are not available in the valuation snapshot, but the company reported a last actual EPS of 9.09 JPY and revenue of 3.2 billion JPY, suggesting a modest scale of operations. The absence of ROIC, EBITDA margins, or other industry_config-preferred metrics limits direct comparison to cohort medians. The company operates in three segments: Hygiene Inspection Equipment, PIM, and Semiconductor Materials. Revenue concentration data is not disclosed, but the company's exposure to the healthcare and semiconductor industries suggests potential sensitivity to sector-specific demand cycles. Growth trajectory is not quantified in the outlook, but the company's current revenue of 3.2 billion JPY implies a need for significant revenue expansion to scale. No forward-looking guidance is provided for the current or next fiscal year. Risk factors include unassessed liquidity risk and the absence of disclosed debt or cash reserves. The company has no near-term dilution risk, and no adjustments were applied to valuation metrics. However, the lack of balance-sheet data limits the ability to assess credit risk or capital structure resilience. Recent events include the latest actual EPS and revenue figures, but no filings or transcripts are cited in the input data to suggest operational or strategic changes. The company's business model appears stable but lacks disclosed innovation or expansion plans.

30-day price · 4241-50.00 (-7.3%)
Low$625.00High$892.00Close$636.00As of21 May, 00:00 UTC
Profile
CompanyAtect Corp
Ticker4241.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Atect Corp (4241.T) is a Japanese manufacturer and seller of hygiene inspection equipment, PIM auxiliary agents, and semiconductor materials, primarily serving the healthcare and semiconductor industries.

Classification. Atect Corp is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Atect Corp's capital structure is characterized by a lack of disclosed balance-sheet liquidity metrics, and its liquidity risk remains unassessed due to missing inputs and no going-concern language in source documents. The company has no dilution risk in the near term, as shares outstanding remain unchanged between basic and diluted shares. Profitability metrics are not available in the valuation snapshot, but the company reported a last actual EPS of 9.09 JPY and revenue of 3.2 billion JPY, suggesting a modest scale of operations. The absence of ROIC, EBITDA margins, or other industry_config-preferred metrics limits direct comparison to cohort medians. The company operates in three segments: Hygiene Inspection Equipment, PIM, and Semiconductor Materials. Revenue concentration data is not disclosed, but the company's exposure to the healthcare and semiconductor industries suggests potential sensitivity to sector-specific demand cycles. Growth trajectory is not quantified in the outlook, but the company's current revenue of 3.2 billion JPY implies a need for significant revenue expansion to scale. No forward-looking guidance is provided for the current or next fiscal year. Risk factors include unassessed liquidity risk and the absence of disclosed debt or cash reserves. The company has no near-term dilution risk, and no adjustments were applied to valuation metrics. However, the lack of balance-sheet data limits the ability to assess credit risk or capital structure resilience. Recent events include the latest actual EPS and revenue figures, but no filings or transcripts are cited in the input data to suggest operational or strategic changes. The company's business model appears stable but lacks disclosed innovation or expansion plans.
Key takeaways
  • Atect Corp operates in niche markets within healthcare and semiconductor materials, with no disclosed diversification.
  • The company's liquidity risk is unassessed, and no balance-sheet data is available to evaluate capital structure.
  • Revenue of 3.2 billion JPY suggests a small scale of operations with no disclosed growth trajectory.
  • No dilution risk is present in the near term, but the lack of financial transparency limits valuation confidence.
  • The company's exposure to healthcare and semiconductor industries may make it sensitive to sector-specific demand shifts.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric4241Activity
Op margin13.3% medp25 5.9% · p75 13.5%
Net margin8.6% medp25 2.7% · p75 12.7%
Gross margin64.0% medp25 60.1% · p75 65.6%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue3.0% medp25 2.7% · p75 4.5%
Debt / equity69.3% medp25 63.4% · p75 74.5%
Observations
IR observations
Last actual EPS9.09 JPY
Last actual revenue3,201,630,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-03 23:12 UTC#6501425c
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 23:13 UTCJob: 1ecf16e7